The El-Kenawi Lab at Indiana University School of Medicine and the IU Melvin and Bren Simon Comprehensive Cancer Center investigates the metabolic interactions between tumor cells and the immune microenvironment. The lab focuses on how cancer cells exploit neighboring cells to scavenge nutrients and macromolecules, a "symbiotic" scavenging tactic, and how metabolic reprogramming, particularly involving cholesterol, drives resistance to hormone-based therapies in prostate, breast and ovarian cancers. Supported by National Cancer Institute and Department of Defense funding, the El-Kenawi Lab aims to uncover novel therapeutic strategies by targeting cancer metabolism and immune suppression.